Celgene ( Celgene )

Celgene

Celgene's picture

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

Celgene press release, blog etc

07/10/2018 - 12:25 Anti-PD-L1 Immunotherapy Plus ABRAXANE Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study
07/09/2018 - 12:54 Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III BELIEVE' Study in Adults with Transfusion-Dependent Beta-Thalassemia
06/28/2018 - 09:23 Celgene and Acceleron Announce Luspatercept Achieved Primary and Key Secondary Endpoints in Phase III MEDALIST' Study in Patients with Low-to-Intermediate Risk Myelodysplastic Syndromes
06/03/2018 - 08:30 Celgene Announces Updated Safety and Efficacy Data from the TRANSCEND Trial of liso-cel (JCAR017) in Patients with Relapsed or Refractory B-cell non-Hodgkin Lymphoma at ASCO
06/02/2018 - 16:38 We Cant Afford Not To Innovate and Provide Access to the Best Multiple Myeloma Care Possible
06/02/2018 - 10:54 CAR T Cell Research Continues to Advance
06/01/2018 - 09:35 Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relapsed or Refractory Multiple Myeloma
05/31/2018 - 08:14 Celgene Corporation Announces Hiring of David V. Elkins as Executive Vice President, Chief Financial Officer and Appointment of Peter N. Kellogg to Executive Vice President, Chief Corporate Strategy Officer
05/30/2018 - 02:50 MS Progression Linked to Grey Matter Atrophy
05/24/2018 - 06:49 Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program
05/18/2018 - 05:59 What Its Really Like to Live with Ulcerative Colitis
05/18/2018 - 05:52 Understanding the Common Symptoms of Behcets Disease
05/17/2018 - 08:15 ASCO 2018 Preview: Precision Medicine, CAR T Cells and Immunomodulators
05/14/2018 - 08:22 Celgene Corporation to Webcast at Upcoming Investor Conferences and Events
05/10/2018 - 16:28 Health Care Professionals Privacy Notice
05/08/2018 - 07:02 How I Learned About Beta-thalassemia
05/08/2018 - 05:52 Bringing Our Commitment to Patients to Washington, D.C.
04/30/2018 - 07:42 Celgene Corporation Announces Appointment of Jennifer Dudinak to Senior Vice President of Global Regulatory Affairs